greeksoup/ stock research

uniQure N.V. insider trading

In twelve months insiders at uniQure bought nothing and sold $22.1M on the open market; 38 of the 57 sales were under plans set months before.

Bought on the open marketNonein twelve months
Sold on the open market$22.1M57 sales
Sales set in advance38 of 57under Rule 10b5-1 plans
Pay taken in stockNone
New to this? How to read this page
  1. Insiders are the people who run the company: officers, directors and owners of 10% or more. They must report a trade on Form 4 within two business days.
  2. A purchase on the open market is the strongest sign: the insider spent their own money.
  3. A sale under a trading plan (Rule 10b5-1) says little: its dates were fixed months before. Sales outside a plan say more, but insiders sell for many reasons, such as taxes or a house.
  4. Grants, option exercises and shares held back for tax are left out.
  5. What is a Form 4? · Form 4 codes

What kind of trades

Insiders only sold: 57 sales worth $22.1M, and 38 of them were under plans set months before, which say little.

Purchasebought with their own money
Pay in stock, own choiceowed cash, chose shares
Sale outside a planthe insider picked the day
Sale under a plandates fixed months before
Says littlecompany plans, board pay, cash units
Bought
none
Sold
19 outside a plan38 under a plan

Every Form 4 line of the last twelve months, counted by kind. The grades come from the filing itself: whether the insider paid cash, whether a plan set the date, whether pay was taken in stock by choice.

Insider trades on the share price

last twelve months

37 marks over twelve months, each in its grade: solid for the stronger signs, hollow or grey for the ones that say little.

PurchasePay in stock, own choiceSale outside a planSale under a planSays little

The blue line is the daily close over twelve months. Each mark is one insider's trades on one day, on that day's price, sized by dollar value. Solid marks are the stronger signs; hollow and grey marks say little. Hover or tap a mark for who, how much and why.

Trades worth a closer look

A purchase stands out when two or more of these hold: a senior insider, several insiders buying within 90 days, a fall of 10% or more in the three months before, or over $1 million. A sale outside a plan is judged the same way. These are the Feed's rules.

Who traded

dollars, twelve months

12 insiders traded. The most: Kapusta Matthew C, sale outside a plan $770K; sale under a plan $12.1M.

One row per insider, sold to the left and bought to the right, split by grade: the paler part of a bar is the part that says little.

How it compares

every company on the site

Open-market sales, twelve months

Open-market purchases, twelve months

    The bar ranks every company on the site from the lowest on the left to the highest on the right, in three equal thirds; the small figures under it are the values where each third starts, and the black tick is the middle company. The orange dot is this company; the grey ticks are the other companies in its industry (hover or tap for names). A hatched block is companies tied at none.

    Every Form 4 line

    Purchase: bought on the open market with their own moneyTook pay in stock, own choice: owed cash, chose shares instead; a softer signSale: sold on the open market, not under a plan set in advanceSale, trading plan: under a Rule 10b5-1 plan set up months before, so the date was fixed in advanceGrey lines: plan purchases, pay in stock taken by the whole board or under a company plan, and units paid in cash; they say little about the insider's own view
    TradedInsiderRoleTypeSharesPriceValueFiling
    2 July 2026Kapusta Matthew CCEO, Managing DirectorSaletrading plan set in advance · Form 144 notice 2 July 20269,200$44.43$408,756Form 4
    2 July 2026Kapusta Matthew CCEO, Managing DirectorSaletrading plan set in advance · Form 144 notice 2 July 20264,282$45.43$194,531Form 4
    2 July 2026Kapusta Matthew CCEO, Managing DirectorSaletrading plan set in advance · Form 144 notice 2 July 20267,600$45.89$348,764Form 4
    30 June 2026Abi-Saab WalidChief Medical OfficerSaletrading plan set in advance · Form 144 notice 30 June 202610,000$46.46$464,600Form 4
    30 June 2026Abi-Saab WalidChief Medical OfficerSaletrading plan set in advance · Form 144 notice 30 June 202620,000$46.40$928,000Form 4
    30 June 2026Kaye JackDirectorSaletrading plan set in advance · Form 144 notice 30 June 20264,107$46.49$190,934Form 4
    30 June 2026Kaye JackDirectorSaletrading plan set in advance · Form 144 notice 30 June 202617,060$46.43$792,096Form 4
    26 June 2026Abi-Saab WalidChief Medical OfficerSaleafter a 222% rise over three months · 33% below its one-year high · Form 144 notice 26 June 20261,434$46.86$67,197Form 4
    25 June 2026Kapusta Matthew CCEO, Managing DirectorSaletrading plan set in advance · Form 144 notice 25 June 202628,716$50.02$1.4 millionForm 4
    24 June 2026Kapusta Matthew CCEO, Managing DirectorSaletrading plan set in advance · Form 144 notice 25 June 20266,696$50.00$334,800Form 4
    18 June 2026Kapusta Matthew CCEO, Managing DirectorSaletrading plan set in advance · Form 144 notice 18 June 20264,656$50.00$232,800Form 4
    18 June 2026Kapusta Matthew CCEO, Managing DirectorSaletrading plan set in advance · Form 144 notice 18 June 202637,015$50.00$1.9 millionForm 4
    17 June 2026Kapusta Matthew CCEO, Managing DirectorSaletrading plan set in advance · Form 144 notice 18 June 202623,977$42.61$1.0 millionForm 4
    17 June 2026Kapusta Matthew CCEO, Managing DirectorSaletrading plan set in advance · Form 144 notice 18 June 20266,023$43.70$263,205Form 4
    17 June 2026Kapusta Matthew CCEO, Managing DirectorSaletrading plan set in advance · Form 144 notice 18 June 202632,581$45.02$1.5 millionForm 4
    17 June 2026Kapusta Matthew CCEO, Managing DirectorSaletrading plan set in advance · Form 144 notice 18 June 202656,929$43.43$2.5 millionForm 4
    17 June 2026Kapusta Matthew CCEO, Managing DirectorSaletrading plan set in advance · Form 144 notice 18 June 202633,334$45.01$1.5 millionForm 4
    17 June 2026Kapusta Matthew CCEO, Managing DirectorSaletrading plan set in advance · Form 144 notice 18 June 202611,585$48.65$563,610Form 4
    17 June 2026Balachandran MadhavanDirectorSaletrading plan set in advance · Form 144 notice 17 June 20265,295$47.08$249,289Form 4
    17 June 2026Balachandran MadhavanDirectorSaletrading plan set in advance · Form 144 notice 17 June 20264,700$43.66$205,202Form 4
    17 June 2026Balachandran MadhavanDirectorSaletrading plan set in advance · Form 144 notice 17 June 20261,690$42.60$71,994Form 4
    17 June 2026Kaye JackDirectorSaletrading plan set in advance · Form 144 notice 17 June 20265,295$42.57$225,408Form 4
    15 June 2026Balachandran MadhavanDirectorSaletrading plan set in advance · Form 144 notice 11 June 202610,000$27.85$278,500Form 4
    15 June 2026Potts JeannetteChief Legal OfficerSaleafter a 75% rise over three months · 61% below its one-year high · Form 144 notice 15 June 20265,237$27.67$144,908Form 4
    11 June 2026Meek David D.DirectorSaleafter a 58% rise over three months · 62% below its one-year high · Form 144 notice 11 June 20261,993$27.06$53,931Form 4
    11 June 2026Gut RobertDirectorSaletrading plan set in advance · Form 144 notice 11 June 20262,726$27.06$73,766Form 4
    11 June 2026O'Keefe KylieChief Customer & Strat OfficerSaleafter a 58% rise over three months · 62% below its one-year high · Form 144 notice 11 June 202615,936$27.06$431,228Form 4
    11 June 2026Springhorn Jeremy P.DirectorSaleafter a 58% rise over three months · 62% below its one-year high · Form 144 notice 11 June 20261,993$27.06$53,931Form 4
    11 June 2026Post Leonard EDirectorSaleafter a 58% rise over three months · 62% below its one-year high · Form 144 notice 11 June 20261,993$27.06$53,931Form 4
    11 June 2026Kaye JackDirectorSaleafter a 58% rise over three months · 62% below its one-year high · Form 144 notice 11 June 20261,993$27.06$53,931Form 4
    11 June 2026Jacques Rachelle SuzanneDirectorSaleafter a 58% rise over three months · 62% below its one-year high · Form 144 notice 11 June 20261,993$27.06$53,931Form 4
    11 June 2026Balachandran MadhavanDirectorSaleafter a 58% rise over three months · 62% below its one-year high · Form 144 notice 11 June 20261,993$27.06$53,931Form 4
    10 June 2026Gut RobertDirectorSaletrading plan set in advance · Form 144 notice 11 June 20262,645$26.07$68,955Form 4
    10 June 2026Gut RobertDirectorSaletrading plan set in advance · Form 144 notice 11 June 20263,127$26.03$81,396Form 4
    10 June 2026Gut RobertDirectorSaletrading plan set in advance · Form 144 notice 11 June 20261,780$26.05$46,369Form 4
    3 June 2026Kaye JackDirectorSaletrading plan set in advance · Form 144 notice 3 June 20262,645$30.01$79,376Form 4
    8 May 2026Abi-Saab WalidChief Medical OfficerSaletrading plan set in advance · Form 144 notice 8 May 202625,000$25.10$627,500Form 4
    8 May 2026Abi-Saab WalidChief Medical OfficerSaletrading plan set in advance · Form 144 notice 8 May 202620,000$25.00$500,000Form 4
    4 March 2026Kapusta Matthew CCEO, Managing DirectorSaleafter a 65% fall over three months · 87% below its one-year high · Form 144 notice 4 March 202614,581$9.06$132,104Form 4
    4 March 2026Abi-Saab WalidChief Medical OfficerSaleafter a 65% fall over three months · 87% below its one-year high808$9.06$7,320Form 4
    4 March 2026Potts JeannetteChief Legal OfficerSaleafter a 65% fall over three months · 87% below its one-year high · Form 144 notice 4 March 20263,412$9.06$30,913Form 4
    4 March 2026Klemt ChristianChief Financial OfficerSaleafter a 65% fall over three months · 87% below its one-year high · Form 144 notice 4 March 202612,000$9.06$108,720Form 4
    2 March 2026Kapusta Matthew CCEO, Managing DirectorSaleafter a 60% fall over three months · 85% below its one-year high · Form 144 notice 2 March 202634,437$9.95$342,648Form 4
    2 March 2026Klemt ChristianChief Financial OfficerSaleafter a 60% fall over three months · 85% below its one-year high · Form 144 notice 2 March 202612,532$9.95$124,693Form 4
    2 March 2026Potts JeannetteChief Legal OfficerSaleafter a 60% fall over three months · 85% below its one-year high · Form 144 notice 2 March 20268,578$9.95$85,351Form 4
    2 March 2026Abi-Saab WalidChief Medical OfficerSaleafter a 60% fall over three months · 85% below its one-year high1,660$9.95$16,517Form 4
    25 February 2026Kapusta Matthew CCEO, Managing DirectorSaleafter a 10% fall over three months · 65% below its one-year high · Form 144 notice 25 February 202612,378$23.86$295,339Form 4
    25 February 2026Klemt ChristianChief Financial OfficerSaleafter a 10% fall over three months · 65% below its one-year high · Form 144 notice 25 February 20266,217$23.86$148,338Form 4
    12 January 2026Gut RobertDirectorSaletrading plan set in advance · Form 144 notice 12 January 202617,310$24.39$422,191Form 4
    12 January 2026Gut RobertDirectorSaletrading plan set in advance · Form 144 notice 12 January 2026500$25.03$12,515Form 4
    12 January 2026Gut RobertDirectorSaletrading plan set in advance · Form 144 notice 12 January 20267,803$25.09$195,777Form 4
    9 January 2026Kaye JackDirectorSaletrading plan set in advance · Form 144 notice 9 January 20266,390$27.28$174,319Form 4
    6 November 2025Gut RobertDirectorSaletrading plan set in advance · Form 144 notice 6 November 202515,840$27.22$431,165Form 4
    6 November 2025Gut RobertDirectorSaletrading plan set in advance · Form 144 notice 6 November 202515,594$27.30$425,716Form 4
    4 November 2025Kaye JackDirectorSaletrading plan set in advance · Form 144 notice 4 November 202510,000$30.36$303,600Form 4
    4 November 2025Kaye JackDirectorSaletrading plan set in advance · Form 144 notice 4 November 202511,000$30.34$333,740Form 4
    4 November 2025Kaye JackDirectorSaletrading plan set in advance · Form 144 notice 4 November 202517,810$30.33$540,177Form 4
    A filing with several lines appears once per line.
    Read morePay taken in stock by the insider's own choice has the filing's footnote, word for word, in the note under it; for the others, hold the pointer on the type. An award filed at no price shows n/a.